SUNSENSE FACE ULTRA LIGHT SPF 50+

Pajjiż: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

bemotrizinol, Quantity: 22 mg/g; diethylamino hydroxybenzoyl hexyl benzoate, Quantity: 42 mg/g; ethylhexyl triazone, Quantity: 6.8 mg/g; octyl methoxycinnamate, Quantity: 60 mg/g; titanium dioxide, Quantity: 31.94 mg/g

Disponibbli minn:

Ego Pharmaceuticals Pty Ltd

Għamla farmaċewtika:

Lotion

Kompożizzjoni:

Excipient Ingredients: alkyl (C12-15) benzoate; 1,2-hexanediol; aluminium magnesium silicate; betaine; cetyl alcohol; dicaprylyl carbonate; diethylhexyl-2,6-naphthalate; dimeticone 350; disodium edetate; glycerol; isopropyl myristate; isostearic acid; myristyl alcohol; neopentyl glycol diheptanoate; nicotinamide; potassium cetyl phosphate; povidone; PVP/eicosene copolymer; colloidal anhydrous silica; purified talc; ammonium acryloyldimethyltaurate/VP copolymer; mixed (low-alpha type) tocopherols concentrate; purified water; xanthan gum; methyl hydroxybenzoate; propyl hydroxybenzoate

Rotta amministrattiva:

Topical

Indikazzjonijiet terapewtiċi:

May assist in preventing some skin cancers (sunscreen) ; May reduce the risk of some skin cancers (sunscreen) ; SPF 50 PLUS Broad spectrum very high protection sunscreen ; Can aid in the prevention of premature skin ageing (sunscreen) ; Can aid in the prevention of solar keratosis (sunscreen) ; Can aid in the prevention of sunspots (sunscreen)

Sommarju tal-prodott:

Visual Identification: ;

L-istatus ta 'awtorizzazzjoni:

Listed

Data ta 'l-awtorizzazzjoni:

2023-01-27